Key facts
- This page summarizes Michael B. Hoffman's Form 4 filing for Annovis Bio, Inc. (ANVS).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Dec 2025, 20:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Purchase
No transaction description listed
Additional SEC filing notes
Footnote F1
The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares.